Fortis Healthcare Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Fortis Healthcare announces Q4 FY26 and FY26 Financial Results".
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong Q4 FY26 and full-year FY26 results. Consolidated revenue grew 17.8% to INR 2,365 Cr in Q4 and 17.3% to INR 9,128 Cr for FY26. Operating EBITDA surged 22.2% in Q4 and 31.3% for the full year, with margins expanding to 22.8% vs 20.4% in FY25, driven by both hospital (22.2% margin, up from 20.5%) and diagnostics (23.6% margin, up from 17.7%) businesses. PAT grew 44.2% to INR 271 Cr in Q4 and 31.5% to INR 1,064 Cr for FY26. The company acquired People Tree Hospital (Bengaluru, ~125 beds) and Shrimann Hospital (Jalandhar, ~228 beds), adding ~500 beds through inorganic growth. Net debt stood at INR 2,334 Cr with Net Debt/EBITDA at 1.09x. The board recommended a dividend of INR 1 per share.
Strong margin expansion and profitability growth are positive signals for investors. The increase in net debt due to acquisitions warrants monitoring, but the EBITDA growth is tracking well to support the higher leverage.